Cell surface receptors that are coupled to heterotrimeric guanine nucleotide-binding proteins (G proteins) function in signal transduction pathways that allow eukaryotic cells to respond to various hormones, neuroregulatory molecules, and sensory stimuli. In these pathways, receptors program cellular responses by interacting specifically with certain ligands and G proteins. G-protein-coupled receptors are subjected to regulatory processes involving receptor phosphorylation, sequestration, and down-regulation which limit the strength or duration of physiological responses (4, 15, 36) .
Recent investigations are beginning to address the molecular mechanisms by which receptors are activated by specific ligands and undergo agonist-induced sequestration and downregulation. An emerging theme is that membrane-spanning as well as cytoplasmic domains of G-protein-coupled receptors can have roles in these processes (12, 18, 22, 39, 40, 48) . Mutagenesis and domain swapping experiments have indicated, for example, that the third cytoplasmic loops of certain mammalian receptors control G-protein activation, receptor sequestration, and responses to partial agonists (6, 10, 11, 13, 19, 28-30, 42, 43) . Indeed, in ,-adrenergic receptors, discrete subdomains of the third cytoplasmic loop apparently control subsets of these processes, because mutant receptors that are sequestered normally but exhibit defective G-protein activation and receptor down-regulation have been constructed (6, 10).
In the yeast Saccharomyces cerevisiae, the oligopeptide mating pheromones a-factor and ox-factor act via G-proteincoupled receptors in a pathway that triggers several physiolog-ical responses, including cell cycle arrest, transcription of certain genes, and morphological changes, which prepare cells for mating (27, 46) . These physiological responses have been used to show that oa-factor receptors can discriminate between their cognate ligand and foreign peptides, such as the x-factor antagonist des-Trp'-[Ala3, Nle12]cj-factor (16, 37) and the (x-factor-related pheromone from the yeast Saccharomyces kluyveri (32) . Indeed, mutant a-factor receptors bearing substitutions in various transmembrane domains that respond to these foreign peptides have been identified (31) .
Pheromone receptors also participate in adaptation or desensitization networks that promote recovery from pheromone action (4) . Two distinct mechanisms, ligand-induced internalization and phosphorylation, involve the C-terminal cytoplasmic domain of the receptor (25, 38, 41) . These regulatory events are independent of Sst2p (21, 25, 38) , a novel 80-kDa regulatory protein that promotes recovery or desensitization by unknown mechanisms (8, 9, 14) . However, Sst2p and pheromone receptors may be functionally linked in some way, because reducing the coupling efficiency between ox-factor receptors and G proteins promotes the function of an Sst2p-dependent desensitization pathway (49) . Sst2p and the cx-factor receptor may therefore function in a related process that controls pheromone response and/or desensitization.
To explore how the o.-factor receptor is activated by its agonist and controls pheromone response and desensitization, we have identified and characterized novel ste2 mutations that affect the third cytoplasmic loop of the receptor and confer pheromone-supersensitive phenotypes. Genetic interactions between these ste2 mutations and sst2 mutations have been used in further tests of determining whether ox-factor receptors and Sst2p control a related signalling and/or desensitization process. Furthermore, we have examined whether these ste2 mutations influence the ability of o-factor receptors to signal in S. cerevisiae strains, plasmids, and genetic methods. The S. cerevisiae strains used in these studies are listed in Table 1. KBY16 was constructed as an ste2A::LEU2 sstlA derivative of a segregant from a cross between JE103 and YM4126. Plasmids used for disrupting the STE2 and SST1 genes have been described previously (38) . KBY12B was constructed by using NheI-cut pBC14 (13a, 38) to disrupt the SST2 gene in KBY16 by two-step gene replacement; halo assays were used to confirm the sst2 disruptions. pRS314STE2 has been described previously (49) . pRS316STE2 was constructed by isolating a 4.3-kb BamHI fragment encompassing the STE2 locus and inserting it into BamHI-cut pRS316 (44) . Dominance tests were performed by coexpressing various ste2 alleles on pRS314 derivatives and the wild-type STE2 allele on pRS316STE2 in a ste2A::LEU2 mutant (JEl 15) and assaying for pheromone sensitivity, as described below.
Oligonucleotide-directed mutagenesis, sequence analysis, and plasmid recovery. The collection of random mutations in the region of pRS314STE2 encoding residues 233 to 243 of the STE2 gene product has been described previously (49) . The mutagenesis method of Kunkel et al. (26) on plates containing 10 nM at-factor but were able to grow on plates containing 1 nM at-factor. After replica plating, transformants that failed to grow on plates containing 0.1 or 1 nM a-factor were analyzed further. To determine whether the pheromone-supersensitive phenotypes of these isolates were conferred by plasmid-borne mutations, plasmids were transferred from S. cerevisiae to E. coli and introduced back into the ste2A::LEU2 strain JE15. These transformants were subjected to quantitative assays of pheromone response, as described below. Pheromone response assays. Bioassays (halo assays) were used to measure the apparent sensitivity of cells to pheromoneinduced growth arrest (45) . Cells (104) expressing wild-type or putative mutant receptors were embedded in soft agar, and disks containing various concentrations of synthetic a-factor were placed on the agar surface. After a 48-h incubation at 30°C, the zones of growth inhibition (halos) in the cell lawn were measured. By interpolation of dose-response curves, the relative pheromone sensitivities of strains expressing various ste2 alleles were determined by estimating the amount of at-factor required to form a halo 20 mm in diameter. Pheromone response was also quantified by measuring the expression of the pheromone-inducible FUSI-lacZ reporter gene in plasmid pSL307 (33) . Cells carrying plasmids pSL307 and pRS314STE2 expressing various ste2 alleles were grown in selective medium to a density of 107 cells per ml. Cultures were split into aliquots, and various concentrations of at-factor were added. After a 2-h incubation at 30°C, cells were permeabilized and assayed for 3-galactosidase activity (45) . Pheromone sensitivity was assessed by using dose-response curves to estimate the concentration of at-factor needed to give a 50% maximal response.
Quantitative mating assays were essentially performed as previously described (31, 32 Measurement of receptor internalization. Rates of ligandindependent and ligand-induced loss of ox-factor binding sites from the cell surface were measured as previously described (21, 38) , with the following modifications. Cells were grown at 22°C in selective medium (SD-tryptophan) to a cell density of 107 cells per ml and treated with cycloheximide (20 pLg/ml) for 5 min. For determining basal rates of receptor internalization, ot-factor was omitted; for determining pheromone-induced rates of receptor internalization, ot-factor was added to a final concentration of 50 nM. Aliquots of cells were removed at various times, treated with 10 mM NaN3 and 10 mM NaF, and washed in 10 mM H3PO4, pH 1.8, to remove surface-bound ot-factor. After cells were washed in YPBI (2), they were incubated with 35S-labeled a-factor (10 nM, 30 Ci/mmol) with or without a 500-fold excess of unlabeled synthetic ot-factor, which was used to determine levels of nonspecific binding. Control cells were quenched with metabolic inhibitors (NaN3 plus KF) immediately after treatment with cycloheximide and prior to addition of pheromone and otherwise were treated identically.
RESULTS
Identification of ste2 mutations that confer pheromone-supersensitive phenotypes. To identify mutations in the STE2 gene that may potentiate pheromone response, we used oligonucleotide-directed mutagenesis of a plasmid-borne STE2 gene to introduce random mutations in the region coding for the third putative cytoplasmic loop of the ot-factor receptor ( Fig. 1) (5, 7, 34) . Certain alterations in the third cytoplasmic loop might potentiate signalling, because we previously described substitutions in this region that cause pheromone-resistant phenotypes and impair receptor-G-protein coupling in vitro (49) . Accordingly, the library of mutagenized plasmids was screened for mutations in the STE2 gene that conferred an ax-factor pheromone-supersensitive phenotype in growth arrest assays. The library of mutagenized pRS314STE2 plasmids was introduced by transformation into an ste2.::LEU2 strain (JE115). Forty colonies (which arose at a frequency of -3%) were identified by replica plating that failed to grow on medium containing concentrations of at-factor that were insufficient to arrest the growth of cells expressing wild-type at-factor receptors. When these 40 isolates were tested again by replica plating, 5 still displayed a supersensitive phenotype. These isolates were analyzed further.
Plasmids isolated from the five clones were able to confer a pheromone-supersensitive phenotype when reintroduced into an ste2A::LEU2 strain, demonstrating that the supersensitive phenotypes were plasmid dependent. As (5, 7, 34) . The amino terminus (H2N) is positioned extracellularly, and the carboxyl terminus resides cytoplasmically. The expanded sequence includes portions of the fifth and sixth transmembrane domains (TMD5 and TMD6, overlined residues), and the putative third cytoplasmic loop (13, bold letters); every 10th amino acid in the loop is marked according to its position in the wild-type Ste2p sequence. Sequences encoding amino acids 233 to 243 in 13 were subjected to random, oligonucleotidedirected mutagenesis. Amino acid residues altered in the third loops of receptors encoded by various ste2?sf alleles are underlined. The oneletter amino acid code is used. mating efficiency (mating frequencies of >80% of those of wild-type controls; data not shown). The five plasmids carry recessive ste2 mutations, because when they were introduced into ste2zA::LEU2 cells (JE115) expressing wild-type receptors from plasmid pRS316STE2, wild-type pheromone sensitivity was observed as determined by halo assay (data not shown); thus, these mutations were termed ste2s' (supersensitive) alleles. Sequence analysis of these five plasmids revealed that four sets of mutations were isolated, resulting in the following alterations of the receptor polypeptide ( Fig. 1 ): G237A (one plasmid); G237R (one plasmid); a complex series of substitutions in which 0-240 was replaced by a histidine residue, followed by the dipeptide DS, and D-242 was replaced by a histidine residue (two plasmids); and a set of three substitutions R2331 R234K K239N (one plasmid). In the case of the complex mutation (which was termed ste2-al) and the triple mutation (which was termed ste2-a3), site-directed mutagenesis was used to determine which lesions caused the supersensitive phenotypes. Of the substitutions that composed the complex mutation ste2-al, neither a Q240H nor D242H substitution conferred a supersensitive phenotype, whereas insertion of the dipeptide DS between residues 240 and 241 (which was termed ste2-a2) was sufficient to confer a supersensitive phenotype (see below). Likewise, among the three substitutions caused by ste2-a3, only the single substitution K239N caused a detectable supersensitive phenotype on its own (data not shown). Therefore, although a collection of randomly induced mutations were screened, only mutations that affected residues in the C-terminal one-half of the third loop were recovered. However, it is possible that mutations affecting other regions of the third loop could also cause a supersensi-VOL. 14, 1994 on (Fig. 3) . The apparent concentrations of ct-factor that gave 50% maximal response for FUSJ-lacZ induction in these strains were as follows: wild-type STE2, 35 nM; ste2-al, 6 nM; ste2-a2, 6 nM; ste2-a3, 8 nM; ste2G237A, 8 nM; ste2G237R, 10 nM; and ste2K239N, 12 nM. As summarized in Table 2 , these values and data obtained from cell cycle arrest assays yielded similar estimates of the relative sensitivity of cells expressing a given ste2"s allele. Because the results obtained from short-and long-term assays of pheromone response were similar, steZsI mutations apparently influence pheromone sensitivity by increasing initial signalling efficiency.
However, we cannot completely rule out that ste2Ts' mutations derivatives and carrying a FUSI-lacZ plasmid (pSL307) were used for transcriptional induction assays. Cells were treated with increasing concentrations of et-factor (M, molar) for 2 h at 30°C. ,B-Galactosidase activity in permeabilized cells was measured as previously described (45) . The data shown are the averages from at least six assays performed in duplicate. The standard deviations for data shown were less than 20%. The standard deviations for actual maximal responses are shown in Table 3 . G237A, ste2G237A; G237R, ste2G237R; K239N, ste2K239N. also cause pheromone-supersensitive phenotypes by delaying recovery from pheromone-induced GI arrest, because performing direct, quantitative measurements of recovery rates is difficult owing to the modest effects of these mutations.
Genetic interactions between ste2"s' alleles and sst2 mutations. Prior genetic studies have implied that the third cytoplasmic loop of the ox-factor receptor and the regulatory protein Sst2p function in a related process that controls pheromone response and/or desensitization (49) . The availability of ste2-sI alleles provided the following means of testing this hypothesis further. If ste26X' and sst2 mutations control pheromone sensitivity independently of one another, then ste2''' sst2 double mutants should be more sensitive than an isogenic STE2 sst2 strain. Conversely, if ste27' and sst2 mutations affect related processes that control pheromone sensitivity, then ste2-' sst2 double mutants should not be more sensitive than STE2 sst2 cells.
To test these predictions, we expressed the wild-type STE2 gene and various ste2vvI alleles in various sst2 (sstl]A sst2A, SSTI sst2-4"', and SSTI sst2-1) mutant backgrounds. Pheromone sensitivities of the resultant cells were inferred from doseresponse relationships established by halo assays. As indicated by the results summarized in Table 2 , ste2.s' sst2 double mutants (either in SSTJ or sstlA backgrounds) were not more sensitive than STE2 sst2 cells. These results must be viewed cautiously, because mutations affecting distinct regulatory mechanisms that control pheromone sensitivity are not always directly additive (38) .
Two examples of complex genetic interactions between ste2"' and sst2 mutations were also observed that further suggest an interaction between STE2 and SST2. In an SSTJ sst2-1 background, the ste2sI' alleles ste2-al and ste2-a3 caused a lower cellular sensitivity than that of the STE2 SSTJ sst2-1 control. Because sst2-1 is a missense mutation that produces full-length Sst2p (14a), the mutant form of Sst2p may interfere with some aspect of receptor function. Taken together, the results are consistent with prior indications (49) that the third loop of the (x-factor receptor and Sst2p function in a related process that controls pheromone response and/or desensitization.
Ligand binding properties and cell surface expression of mutant receptors. One way that signalling efficiency could be increased by expression of ste25s' alleles is if mutant receptors were to bind at-factor with higher affinity. Accordingly, the ligand binding characteristics of wild-type and mutant receptors were compared in equilibrium binding assays that employed 35S-labeled a-factor and intact, inviable cells (JE115). The results of these experiments (Fig. 4) indicated that the apparent equilibrium dissociation constant (K,d) for wild-type receptors was 3.8 nM, and with one exception, the Kd values for the mutant receptors were similar, ranging from 1.4 to 6 nM. Comparisons of the binding data shown in Fig. 4 and pheromone sensitivity data summarized in Table 2 indicated that increased pheromone binding affinity was not always correlated with increased pheromone sensitivity. An exception, however, was the ste2-al mutant, which expressed receptors that bound at-factor with the highest affinity (K,, = 0.2 nM) and displayed the strongest supersensitive phenotype.
Results of ligand binding assays also indicated that the ste2-al and ste2-a3 alleles decreased the steady-state levels of receptors at the cell surface (Bmax) approximately three-to fourfold (Fig. 4) . In principle, these effects could be due to ligand-induced down-regulation of mutant receptors in response to low levels of ax-factor that would be produced by cells (ste2-a3), and 1.8 x 1(7 (G237A and G237R), in a final volume of 110 ,ul for STE2, ste2-a3, K239N, G237A, and G237R and 410 [l for ste2-aI.
G237A, sste2G237A; G237R, ste2G237R; K239N, ste2K239N. in the population that have undergone mating type switching. However, this explanation was ruled out because relative to normal receptors, mutant receptors were still expressed at reduced levels in cells with both cr-factor structural genes deleted (KBY16) (data not shown).
Internalization of receptors encoded by ste255' alleles. Reduced cell surface expression of mutant receptors could also be due to constitutive or ligand-independent internalization. This possibility was examined by determining the rates of ligandindependent and -dependent receptor internalization for cells expressing wild-type receptors or representative mutant receptors that exhibit normal (ste2G237A) or reduced (ste2-al) cell surface expression. Wild-type and mutant receptors were expressed in cells (KBY16) with deletions of both a-factor structural genes to eliminate the potentially confounding effects of endogenously produced cr-factor.
Receptor internalization was monitored by measuring the disappearance of cr-factor binding sites from the surfaces of living cells in which the synthesis of new receptors was blocked by cycloheximide treatment. For determining rates of liganddependent internalization, unlabeled cr-factor (50 nM) was added to cycloheximide-treated cells. Aliquots removed at various times were treated with metabolic inhibitors to prevent further internalization, and surface-bound, unlabeled cr-factor was removed by washing the cells with a solution with a low pH. The levels of receptors remaining on the cell surface were determined by conducting radioligand binding assays. Identical procedures were used for determining rates of ligand-independent internalization, except that unlabeled cr-factor was omitted from the culture medium of cycloheximide-treated cells. As a control for monitoring the recovery of receptor binding sites, parallel cultures were treated simultaneously with cycloheximide and metabolic inhibitors and processed as described above.
The results obtained from receptor internalization assays are shown in Fig. 5 . Under the conditions employed, wild-type receptors were internalized more slowly [half-life (t1,2) >90 min, although internalization kinetics were complex] in the absence of cr-factor and more rapidly (t112 20 min) in its presence. Similar results were obtained with cells bearing the ste2G237A allele, which express normal levels of receptors at their surface. However, in cells expressing the ste2-al allele, receptors were internalized rapidly (t112 20 to 30 min) either in the absence or presence of cr-factor. Therefore, in cells expressing the ste2-al mutation, rapid ligand-independent internalization probably reduces the levels of receptors present at the cell surface.
Receptors encoded by ste2"st alleles require ligand for signal transduction. Because one type of mutant receptor (ste2-al) was internalized in a ligand-independent manner, it may, to some extent, activate the pheromone response pathway in the absence of cr-factor. Accordingly, to compare the abilities of mutant and wild-type receptors to activate the pheromone response pathway in a ligand-independent manner, we monitored basal expression levels of FUS]-lacZ in a strain (KBY16) with both cr-factor structural genes disrupted (without ligand [ Table 3 ]). Because these results indicated that the levels of pheromone-independent expression of FUSJ-lacZ were similar in cells expressing wild-type and mutant receptors, there was no indication that any of the mutant receptors was constitutively active.
Cells expressing ste2Sst mutations respond to an a-factor antagonist. When tested against wild-type cells, an cs-factor derivative, des-Trp'-[Ala3, Nle' 2]a-factor, elicits no response on its own, but it prevents cells from responding to cs-factor, apparently by functioning as an antagonist (16, 37) . Therefore, by monitoring FUSI-lacZ expression, we could determine whether cells expressing ste2-' alleles can discriminate between a-factor and an cs-factor antagonist. Again, a strain with both cs-factor structural genes deleted (KBY16) was used in these experiments. Whereas the results of ,B-galactosidase assays (with antagonist [ Table 3 ]) indicated that cells expressing the wild-type STE2 gene did not respond significantly to the cs-factor antagonist, they revealed that cells expressing any of the ste2-sI alleles did respond. Moreover, the strength of the response to antagonist caused by various ste2isf alleles correlated with the strength of the response to pheromone: in mutants that were weakly supersensitive to pheromone (ste2-a3, ste2K239R, and ste2G237R mutants), FUSJ-lacZ expression was induced 3-to 4-fold by the presence of antagonist, whereas in mutants that were strongly supersensitive to pheromone (ste2-al and ste2-a2 mutants), FUSJ-lacZ expression was induced 10-to 15-fold over basal levels.
To determine whether antagonist-responsive phenotypes were conferred generally by any ste2 mutation that causes a pheromone-supersensitive phenotype, we performed similar transcriptional induction experiments with cells expressing ste2 mutations (ste2X408, ste2A381, and ste2A296) that truncate the receptor at various points within its C-terminal domain (38) (with antagonist [ Table 3 ]). Although cells expressing partial C-terminal truncations (ste2A408 and ste2A381) are approximately as pheromone supersensitive (5-to 15-fold by halo assay [38] ) as cells expressing the strongest ste2"' alleles, they responded less well to the cs-factor antagonist (2-fold induction of FUSJ-lacZ). Similarly, cells expressing a complete C-terminal truncation (ste2A296), which can increase pheromone sensitivity more than 100-fold (38) , displayed an antagonistresponsive phenotype that was not appreciably stronger (17-fold induction) than the response that was obtained with the strongest ste2 ¶s' allele, which increases cs-factor sensitivity 15-fold. Moreover, when we used another ligand in similar experiments with ste2"' mutations and ste2 tail truncations (the cs-factor-related peptide from S. kluyveri [31, 32] , which is a weak agonist for wild-type cells), the strongest ste23s' mutants (ste2-al) responded similarly to cells expressing ste2zX296 (data not shown). Therefore, the results of these experiments indicated that the apparent strength of the response to antagonist conferred by ste2''' alleles was not simply directly proportional to pheromone sensitivity, nor was the response ligand specific.
Antagonist binding properties of mutant receptors. Cells expressing steZs' alleles might respond to an cs-factor antagonist because mutant receptors bind the peptide more tightly than wild-type receptors. To test this possibility, we compared the antagonist binding properties of wild-type receptors and representative mutant receptors conferring weak (ste2G237A) and stronger (ste2-al) responses to the antagonist. Antagonist binding affinities were determined by ligand binding assays that employed labeled cs-factor and various concentrations of the unlabeled cs-factor antagonist (des-Trpt-[Ala3, Nlet 2](X-factor) as a competitor. The results of these experiments are shown in Fig. 6 . Apparent 50% inhibitory concentrations for radioligand binding obtained from these data and the known K,1 values of wild-type and mutant receptors for cs-factor (Fig. 4) were used to calculate the following equilibrium inhibition constants (K,): STE2, 300 nM; ste2G237A, 360 nM; and ste2-al, 300 nM. These results indicated that ste2"' alleles do not confer antagonist-responsive phenotypes by increasing antagonist binding affinity. Accordingly, we suggest that receptors encoded by ste2vs' alleles are defective in ligand discrimination functions that normally prevent receptors from being activated by an a-factor antagonist or other ex-factor-related peptides.
DISCUSSION
We have used random oligonucleotide-directed mutagenesis and genetic screening procedures to identify several novel ste2 mutations (ste2"') that increase pheromone sensitivity 2.5-to 15-fold by altering sequences in the carboxyl-terminal one-half of the third cytoplasmic loop of the S. cerevisiae eL-factor receptor. Our genetic data indicate that the ability of ste2%st mutations to increase pheromone sensitivity is observed in cells that express a functional SST2 gene, which encodes a specialized regulatory protein that limits pheromone response and/or promotes desensitization. Although we find that ste2"' mutations do not constitutively activate the pheromone response pathway, physiological assays and biochemical data indicate that they potentiate pheromone response, permit response to a-factor derivatives that function normally as antagonists or weak agonists, and in one instance cause receptors to undergo constitutive internalization or endocytosis. As discussed below, these findings have implications for understanding how eL-factor receptors and Sst2p control pheromone response and desensitization and how G-protein-coupled receptors switch from inactive to active conformations, discriminate between agonists and antagonists, and undergo endocytosis.
Genetic interactions between STE2 and SST2. Genetic analysis indicates that although ste2s't mutations increase pheromone sensitivity in wild-type cells, they fail to do so in sst2 mutants. Because the effects of ste2vsI and sst2 mutations are not additive, at least two explanations can be suggested. In the trivial case, sst2 mutations, which increase pheromone sensitivity more than 100-fold, simply make it difficult to observe further modest increases in pheromone sensitivity that result from expression of ste2s' mutations. Alternatively, the lack of additive effects could mean that receptors and Sst2p function in the same or a related pathway or process that controls pheromone response and/or desensitization. We currently favor the latter hypothesis because we also find that cells expressing a sst2-1 missense mutation and certain ste2St alleles are less sensitive than sst2-1 STE2 controls are. This effect is apparently due to the properties of the missense form of Sst2p, because it is not observed in an sst2 nonsense mutant. Several lines of evidence therefore point to genetic interactions between STE2 and SST2.
How might ox-factor receptors and Sst2p regulate signal transduction or desensitization? On the one hand, Sst2p could negatively regulate receptor function. However, this cannot be the sole mechanism of SST2 action, because under certain circumstances Sst2p can promote desensitization in a receptorindependent manner (1). Sst2p could negatively regulate Gprotein function in some way, for example, by inhibiting subunit dissociation or by inhibiting exchange or promoting hydrolysis of guanine nucleotides. At least in its simplest form, however, these latter models incorrectly predict that sst2 ste2"sI double mutants should be more sensitive than sst2 mutants expressing wild-type receptors. Clearly, further genetic and biochemical studies are required to address these issues.
The third cytoplasmic loop of the a-factor receptor is a multifunctional regulatory domain. Although physiological evidence suggests that ste2`ss mutations cause pheromonesupersensitive phenotypes by increasing the efficiency of initial signal transduction, these effects could be mediated by several different mechanisms. In one case (ste2-al), improved pheromone binding affinity may enhance pheromone response. Although it is conceivable that the ste2-al mutation directly affects the ligand binding site of the receptor, it is also possible that the structure of the mutant receptor partially mimics the transition state normally induced by agonist binding to wildtype receptors (i.e., with no ligand bound, mutant receptors are in a higher energy state than wild-type receptors are). Accordingly, the free energy of agonist binding would increase, as indicated by lower K, values.
In cells expressing the remaining ste2s' mutant receptors, changes in ot-factor binding affinity are small (about twofold) and variable (some ste2`sI mutations increase ligand binding affinity while others decrease it). Increased pheromone sensitivity is therefore not always strictly correlated with significant increases in pheromone binding affinity. In these instances, mutant receptors may cause supersensitive phenotypes by activating G proteins more efficiently. Curiously, although this model predicts that mutant receptors should be dominant when coexpressed with wild-type receptors, the ste2`vf alleles we have identified are recessive. Whether receptor oligomerization, the existence of "spare receptors" (i.e., receptors expressed in excess over G-protein subunits), or some other phenomenon accounts for this behavior is currently under investigation.
In mammalian systems, receptor activation and response to partial agonists likewise appear to be controlled by the third cytoplasmic loop (13, 17, 29, 35) . Substituting amino acids in the third cytoplasmic loops of adrenergic receptors or transplanting segments of third loop sequences between receptor subtypes can result in constitutive or ligand-independent signalling (24, 42) . In these cases, mutant receptors bind agonists more tightly, and in some cases, the potencies of partial agonists are improved. Current models suggested by these observations imply that in the absence of an agonist, the structure of the C-terminal portion of the third loop constrains adrenergic receptors in an inactive conformation and that agonist binding disrupts this structure, leading to receptor activation (24, 42 glycine residue may be needed for a portion of the loop to assume a structure (13-turn?) that favors the inactive conformation of the receptor. Second, the strongest ste27sI alleles (ste2-aJ and ste2-a2) insert two amino acids into the C-terminal portion of the third loop, which is likely to perturb its native structure. In view of these observations, we suggest that signal transduction between the ligand binding and G protein binding sites of the receptor at least partly involves disrupting the structure of the C-terminal portion of the third intracellular loop. This hypothesis and a prior study (49) therefore imply that the third cytoplasmic loop of the a-factor receptor consists of at least two functional regions, an N-terminal segment important for G-protein activation, and a C-terminal region that functions as part of an agonist-activated conformational switch. This model is strengthened by the fact that it arises from studies employing randomly induced mutations coupled with genetic selection and screening procedures. Therefore, it is noteworthy that a similar subdivision of function has also been suggested for the third cytoplasmic loops of ,-adrenergic receptors (15, 19, 36, 42) , implying that certain mechanistic aspects of signal transduction by G-protein-coupled receptors have been conserved during evolution.
All of the ste2s alleles we have isolated allow cells to respond to an a-factor derivative that normally functions as an antagonist. Several lines of evidence suggest that the antagonist-responsive phenotypes of ste2"st mutants are probably not due to increased antagonist binding affinity; instead they suggest that mutant receptors more readily adopt an active conformation. First, we find that the ste2G237A and ste2-al mutations do not improve antagonist binding affinity of the receptor. Second, the effects of ste2ssf mutations are not ligand specific: they improve response to an ax-factor antagonist as well as to the ax-factor-related peptide produced by the yeast S. kluyveri. Third, the strengths of antagonist-responsive and pheromone-supersensitive phenotypes of ste2ssI mutants are directly correlated.
A fourth line of evidence is suggested by comparing the sequences of pheromone ligands and receptors of S. cerevisiae (34) , S. kluyveri (32) , and S. pombe (23) . The ox-factor peptides from S. cerevisiae and S. kluyveri are unrelated to the P-factor pheromone of S. pombe (50) . Thus, the receptors for these peptides should share few sequence or structural features that are required specifically for recognition of conserved ligand sequences. Remarkably, however, these three distantly related pheromone receptors (12% identity overall) are conserved at positions that are affected by a number of the ste2 mutations described in this study and elsewhere by Marsh (31) , which confer antagonist-responsive and/or pheromone-supersensitive phenotypes (Fig. 7) . Although the precise functions of these residues are unknown, their conservation argues that they may control processes common to these distantly related receptor molecules, perhaps including receptor activation.
Finally, in contrast to wild-type ot-factor receptors, which in the absence of ligand are stably expressed at the cell surface and undergo rapid, ligand-dependent internalization, mutant receptors encoded by the ste2-al allele are internalized rapidly in a ligand-independent manner. Because this finding indicates that the third cytoplasmic loop can provide a signal for receptor internalization, ligand-dependent endocytosis of wildtype receptors may also involve the third cytoplasmic loop. Pheromone binding may induce a conformational change in the third loop which is transmitted to the C-terminal cytoplasmic domain of the ac-factor receptor, a region known to be required for receptor endocytosis (38, 41, 51) . Although this model is similar to a previous one (51) in which the ligandbound (and presumably active) conformation of the receptor triggers endocytosis, it is distinct in the following way. Because we find that mutant receptors undergoing constitutive endocytosis do not constitutively activate the pheromone response pathway, we suggest that the third cytoplasmic loop can adopt different conformations for signalling endocytosis and Gprotein activation. This hypothesis is consistent with prior evidence suggesting that mutant at-factor receptors that couple inefficiently with G proteins apparently undergo normal ligand-induced endocytosis (49) . Indeed, signalling and sequestration functions of G-protein-coupled receptors are genetically separable in other systems as well, because certain mutant 3-adrenergic receptors that couple inefficiently with G, can nonetheless undergo ligand-induced sequestration (6, 10) .
In summary, our results suggest that the third cytoplasmic loop of the S. cerevisiae ox-factor receptor is a multifunctional regulatory domain that influences the processes of receptor activation, ligand discrimination, and internalization.
